Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand. The ‘authorised generic’ uses the same insulin lispro ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 ...

Eli Lilly is gearing up to announce its fiscal 2025 fourth-quarter earnings in the near term, and analysts project its ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- and long-acting insulins.

Oregon’s attorney general filed a lawsuit Wednesday against three insulin manufacturers and the nation’s largest pharmacy benefit managers, or PBMs, alleging they worked together to inflate the price ...

Rokita says Eli Lilly was part of a scheme that inflated insulin prices over the past decade by more than 1000%, despite low manufacturing costs estimated at just a few dollars per vial.

Zepbound can interact with certain medications, including insulin and both prescription and over-the-counter oral medications. While Zepbound isn’t known to interact directly with alcohol, combining ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...